Lansoprazol Krka (Lansoprazole)

Lansoprazole works by irreversibly blocking the H+/K+ ATPase enzyme, also known as the gastric proton pump, on the surface of parietal cells. This inhibition stops the final step of gastric acid secretion, leading to a sustained increase in gastric pH and reduction of acid‑related damage.

The dosage of Lansoprazol Krka is determined by the prescribing healthcare professional based on the specific indication, patient age, renal function and treatment goals. The prescriber will select the appropriate strength, frequency and duration for each individual case.

Safety data for Lansoprazol Krka in pregnancy and lactation are limited. It should be used only if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their healthcare provider.

To order Lansoprazol Krka, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any required import documentation.

Lansoprazol Krka belongs to the same class as omeprazole, esomeprazole and pantoprazole. All PPIs provide comparable acid suppression, but differences exist in metabolism, drug‑interaction profiles and dosing convenience. Lansoprazole is metabolized primarily by CYP2C19 and CYP3A4, which may affect its interaction potential relative to other PPIs.

Store Lansoprazol Krka at room temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure the package is tightly closed to maintain product stability.

Lansoprazol Krka is taken orally. Swallow the tablet whole with a glass of water, preferably before a meal as directed by the prescriber. Do not crush, chew, or split the tablet unless specifically instructed.

Serious risks include severe allergic reactions such as anaphylaxis, Clostridium difficile‑associated colitis, low magnesium levels (hypomagnesemia) with prolonged use, liver inflammation, and rare skin disorders like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience symptoms such as rash, persistent diarrhea, muscle cramps, or signs of an allergic reaction.

Lansoprazol Krka should be avoided in individuals with a known hypersensitivity to lansoprazole, other proton pump inhibitors, or any of the tablet’s excipients. Patients with severe liver disease or those taking medications that require an acidic environment for absorption should consult their physician before use.